Related Experiment Videos
Experiences with thymosin in primary immunodeficiency disease.
Cancer Treatment Reports
|November 1, 1978
Summary
Thymosin did not affect cyclic AMP in thymocytes. In patients, thymosin modulated serum factor (SF) activity and related lymphocyte populations, suggesting a role in immune regulation.
Area of Science:
- Immunology
- Endocrinology
Background:
- Thymosin's role in immune function is complex.
- Serum factor (SF) activity and its target cells are key components of lymphocyte regulation.
Observation:
- In vitro, thymosin did not alter cyclic AMP levels in thymocytes.
- In vivo, thymosin administration affected SF activity and lymphocyte populations.
Findings:
- Patients deficient in SF activity showed induced SF-like activity and reduced target cells after thymosin treatment.
- A patient with normal SF activity experienced decreased SF activity and increased target cells post-thymosin injection.
Implications:
- Thymosin influences serum factor activity and its associated lymphocyte subsets.
- These findings suggest thymosin's potential therapeutic role in modulating immune responses.